Target intelligence / Profile preview

NEK2 pseudogene 2 (NEK2P2)

Target: NEK2P2
Molecular classification: Other (Pseudogene)

Overview

NEK2 pseudogene 2 (NEK2P2) is classified as a pseudogene, a DNA sequence similar to the functional NEK2 gene, but it is generally considered non-functional and does not encode an active protein product. NEK2P2 does not produce the serine/threonine kinase activity attributed to the NEK2 protein, which is implicated in cell cycle regulation, cancer, and centrosome separation[1][2][3][4][5]. There is no evidence that NEK2P2 acts as a therapeutic target, nor is it involved in disease pathogenesis or drug interactions.

Beyond the preview

Go deeper on NEK2 pseudogene 2 (NEK2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NEK2 pseudogene 2 (NEK2P2).

Explore the full profile